annual EBIT:
$7.73M+$13.32M(+237.99%)Summary
- As of today (June 17, 2025), NAGE annual earnings before interest & taxes is $7.73 million, with the most recent change of +$13.32 million (+237.99%) on December 1, 2024.
- During the last 3 years, NAGE annual EBIT has risen by +$34.80 million (+128.54%).
- NAGE annual EBIT is now at all-time high.
Performance
NAGE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$4.77M-$2.34M(-32.89%)Summary
- As of today (June 17, 2025), NAGE quarterly earnings before interest & taxes is $4.77 million, with the most recent change of -$2.34 million (-32.89%) on March 1, 2025.
- Over the past year, NAGE quarterly EBIT has increased by +$5.50 million (+752.80%).
- NAGE quarterly EBIT is now -32.89% below its all-time high of $7.11 million, reached on December 1, 2024.
Performance
NAGE quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$13.23M+$5.50M(+71.23%)Summary
- As of today (June 17, 2025), NAGE TTM earnings before interest & taxes is $13.23 million, with the most recent change of +$5.50 million (+71.23%) on March 1, 2025.
- Over the past year, NAGE TTM EBIT has increased by +$17.59 million (+403.28%).
- NAGE TTM EBIT is now at all-time high.
Performance
NAGE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NAGE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +238.0% | +752.8% | +403.3% |
| 3 y3 years | +128.5% | +161.7% | +148.2% |
| 5 y5 years | +124.7% | +181.0% | +152.2% |
NAGE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +128.5% | -32.9% | +174.7% | at high | +146.8% |
| 5 y | 5-year | at high | +124.7% | -32.9% | +154.0% | at high | +146.8% |
| alltime | all time | at high | +123.3% | -32.9% | +153.9% | at high | +139.2% |
NAGE EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.77M(-32.9%) | $13.23M(+71.2%) |
| Dec 2024 | $7.73M(-238.0%) | $7.11M(+343.9%) | $7.73M(+1628.4%) |
| Sep 2024 | - | $1.60M(-725.8%) | $447.00K(-119.4%) |
| Jun 2024 | - | -$256.00K(-65.0%) | -$2.30M(-47.2%) |
| Mar 2024 | - | -$731.00K(+335.1%) | -$4.36M(-22.1%) |
| Dec 2023 | -$5.60M(-69.9%) | -$168.00K(-85.4%) | -$5.60M(-18.6%) |
| Sep 2023 | - | -$1.15M(-50.5%) | -$6.88M(-21.8%) |
| Jun 2023 | - | -$2.32M(+17.7%) | -$8.79M(-31.6%) |
| Mar 2023 | - | -$1.97M(+36.3%) | -$12.86M(-30.9%) |
| Dec 2022 | -$18.63M(-31.2%) | -$1.44M(-52.9%) | -$18.63M(-17.2%) |
| Sep 2022 | - | -$3.06M(-52.0%) | -$22.50M(-20.4%) |
| Jun 2022 | - | -$6.39M(-17.4%) | -$28.28M(+3.0%) |
| Mar 2022 | - | -$7.73M(+45.4%) | -$27.44M(+1.4%) |
| Dec 2021 | -$27.07M(+36.4%) | -$5.32M(-39.9%) | -$27.07M(-2.7%) |
| Sep 2021 | - | -$8.84M(+59.2%) | -$27.84M(+20.0%) |
| Jun 2021 | - | -$5.55M(-24.6%) | -$23.19M(+8.8%) |
| Mar 2021 | - | -$7.36M(+21.1%) | -$21.33M(+7.4%) |
| Dec 2020 | -$19.85M(-36.6%) | -$6.08M(+44.9%) | -$19.85M(-12.3%) |
| Sep 2020 | - | -$4.20M(+13.8%) | -$22.63M(-10.6%) |
| Jun 2020 | - | -$3.69M(-37.4%) | -$25.32M(-12.1%) |
| Mar 2020 | - | -$5.89M(-33.5%) | -$28.82M(-7.9%) |
| Dec 2019 | -$31.30M(-5.6%) | -$8.86M(+28.6%) | -$31.30M(+2.0%) |
| Sep 2019 | - | -$6.89M(-4.1%) | -$30.68M(-5.3%) |
| Jun 2019 | - | -$7.18M(-14.2%) | -$32.39M(-2.3%) |
| Mar 2019 | - | -$8.37M(+1.6%) | -$33.15M(-0.1%) |
| Dec 2018 | -$33.17M(+102.6%) | -$8.24M(-4.1%) | -$33.17M(-1.6%) |
| Sep 2018 | - | -$8.60M(+8.3%) | -$33.71M(+19.2%) |
| Jun 2018 | - | -$7.94M(-5.5%) | -$28.29M(+23.0%) |
| Mar 2018 | - | -$8.40M(-4.3%) | -$23.00M(+40.5%) |
| Dec 2017 | -$16.38M(+463.7%) | -$8.78M(+176.4%) | -$16.38M(+67.6%) |
| Sep 2017 | - | -$3.18M(+19.8%) | -$9.77M(+29.9%) |
| Jun 2017 | - | -$2.65M(+49.5%) | -$7.52M(+67.2%) |
| Mar 2017 | - | -$1.77M(-18.4%) | -$4.50M(+98.1%) |
| Dec 2016 | -$2.91M | -$2.17M(+135.0%) | -$2.27M(+81.1%) |
| Sep 2016 | - | -$924.20K(-349.0%) | -$1.25M(+728.6%) |
| Jun 2016 | - | $371.10K(-18.4%) | -$151.30K(-78.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $454.90K(-139.4%) | -$705.80K(-65.8%) |
| Dec 2015 | -$2.07M(-60.5%) | -$1.16M(-748.7%) | -$2.07M(+2.6%) |
| Sep 2015 | - | $178.10K(-197.1%) | -$2.01M(-29.1%) |
| Jun 2015 | - | -$183.40K(-79.7%) | -$2.84M(-33.9%) |
| Mar 2015 | - | -$905.40K(-17.9%) | -$4.30M(-17.8%) |
| Dec 2014 | -$5.23M(+19.2%) | -$1.10M(+70.4%) | -$5.23M(+8.0%) |
| Sep 2014 | - | -$647.20K(-60.6%) | -$4.84M(-10.9%) |
| Jun 2014 | - | -$1.64M(-10.7%) | -$5.44M(+13.1%) |
| Mar 2014 | - | -$1.84M(+157.3%) | -$4.81M(+9.6%) |
| Dec 2013 | -$4.39M(-62.3%) | -$714.50K(-42.5%) | -$4.39M(-18.2%) |
| Sep 2013 | - | -$1.24M(+22.6%) | -$5.36M(-5.1%) |
| Jun 2013 | - | -$1.01M(-28.5%) | -$5.65M(-34.5%) |
| Mar 2013 | - | -$1.42M(-16.3%) | -$8.63M(-25.9%) |
| Dec 2012 | -$11.63M(+48.0%) | -$1.69M(+10.5%) | -$11.63M(-6.4%) |
| Sep 2012 | - | -$1.53M(-61.6%) | -$12.42M(-6.5%) |
| Jun 2012 | - | -$3.99M(-9.9%) | -$13.29M(+19.3%) |
| Mar 2012 | - | -$4.42M(+78.2%) | -$11.14M(+41.7%) |
| Dec 2011 | -$7.86M(+289.8%) | -$2.48M(+3.5%) | -$7.86M(+25.4%) |
| Sep 2011 | - | -$2.40M(+30.7%) | -$6.27M(+32.1%) |
| Jun 2011 | - | -$1.83M(+59.8%) | -$4.75M(+48.1%) |
| Mar 2011 | - | -$1.15M(+29.0%) | -$3.20M(+58.9%) |
| Dec 2010 | -$2.02M(+126.0%) | -$889.60K(+1.8%) | -$2.02M(+62.7%) |
| Sep 2010 | - | -$873.70K(+198.0%) | -$1.24M(+129.7%) |
| Jun 2010 | - | -$293.20K(-846.1%) | -$539.50K(+1.2%) |
| Mar 2010 | - | $39.30K(-135.1%) | -$533.20K(-40.3%) |
| Dec 2009 | -$892.70K(-56.7%) | -$111.90K(-35.6%) | -$892.70K(-36.5%) |
| Sep 2009 | - | -$173.70K(-39.5%) | -$1.41M(-27.2%) |
| Jun 2009 | - | -$286.90K(-10.4%) | -$1.93M(-14.9%) |
| Mar 2009 | - | -$320.20K(-48.7%) | -$2.27M(+16.3%) |
| Dec 2008 | -$2.06M(+5275.0%) | -$624.40K(-10.6%) | -$1.95M(+46.7%) |
| Sep 2008 | - | -$698.40K(+11.6%) | -$1.33M(+109.0%) |
| Jun 2008 | - | -$626.00K(>+9900.0%) | -$636.70K(+4581.6%) |
| Feb 2008 | - | -$2900.00(-17.1%) | -$13.60K(-41.6%) |
| Nov 2007 | -$38.40K | -$3500.00(-18.6%) | -$23.30K(+17.7%) |
| Aug 2007 | - | -$4300.00(+48.3%) | -$19.80K(+27.7%) |
| May 2007 | - | -$2900.00(-77.0%) | -$15.50K(+23.0%) |
| Feb 2007 | - | -$12.60K | -$12.60K |
FAQ
- What is Niagen Bioscience annual earnings before interest & taxes?
- What is the all time high annual EBIT for Niagen Bioscience?
- What is Niagen Bioscience annual EBIT year-on-year change?
- What is Niagen Bioscience quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Niagen Bioscience?
- What is Niagen Bioscience quarterly EBIT year-on-year change?
- What is Niagen Bioscience TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Niagen Bioscience?
- What is Niagen Bioscience TTM EBIT year-on-year change?
What is Niagen Bioscience annual earnings before interest & taxes?
The current annual EBIT of NAGE is $7.73M
What is the all time high annual EBIT for Niagen Bioscience?
Niagen Bioscience all-time high annual earnings before interest & taxes is $7.73M
What is Niagen Bioscience annual EBIT year-on-year change?
Over the past year, NAGE annual earnings before interest & taxes has changed by +$13.32M (+237.99%)
What is Niagen Bioscience quarterly earnings before interest & taxes?
The current quarterly EBIT of NAGE is $4.77M
What is the all time high quarterly EBIT for Niagen Bioscience?
Niagen Bioscience all-time high quarterly earnings before interest & taxes is $7.11M
What is Niagen Bioscience quarterly EBIT year-on-year change?
Over the past year, NAGE quarterly earnings before interest & taxes has changed by +$5.50M (+752.80%)
What is Niagen Bioscience TTM earnings before interest & taxes?
The current TTM EBIT of NAGE is $13.23M
What is the all time high TTM EBIT for Niagen Bioscience?
Niagen Bioscience all-time high TTM earnings before interest & taxes is $13.23M
What is Niagen Bioscience TTM EBIT year-on-year change?
Over the past year, NAGE TTM earnings before interest & taxes has changed by +$17.59M (+403.28%)